Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results

Go back to Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
(NASDAQ: NAGE) Delayed: 2.49 -0.09 (3.49%)
Previous Close $2.58    52 Week High $ 
Open $2.58    52 Week Low $ 
Day High $2.59    P/E N/A 
Day Low $2.46    EPS $ 
Volume 555,763